Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995

Archives of Internal Medicine

Volumn 160, Issue 20, 2000, Pages 3136-3140

  Ward, Michael M ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORBIDITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 0034645414     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.20.3136     Document Type: Article

References (27)

1. Contribution of renal biopsy data in predicting outcome in lupus nephritis: Analysis of 116 patients
2. Lupus nephritis: Prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis
3. Clinical prognostic factors in lupus nephritis: The importance of hypertension and smoking
4. Hypertension increases the risk of renal deterioration in systemic lupus erythematosus
5. Lupus in the 1980s, III: Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center
6. Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans
7. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis: Results of a pooled analysis
8. Controlled studies of oral immunosuppressive drugs in lupus nephritis: A long-term follow-up
9. Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs
10. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only
11. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
12. Corticosteroid treatment in systemic lupus erythematosus: Survival studies
13. The management of systemic lupus erythematosus
14. Overview of treatment of lupus nephropathy
15. Long-term prognosis of diffuse lupus nephritis
16. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: A prospective five-year study
17. Management of lupus nephritis
18. The economic impact of treatment of severe lupus nephritis with prednisone and intravenous cyclophosphamide
19. International survey on the management of patients with SLE, III: The results of a questionnaire regarding renal involvement
20. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis
21. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide
22. Systemic lupus erythematosus in Denmark: Clinical and epidemiological characterization of a county-based cohort
23. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992